VITALE, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 14.771
EU - Europa 7.481
AS - Asia 2.545
SA - Sud America 354
Continente sconosciuto - Info sul continente non disponibili 40
AF - Africa 27
OC - Oceania 11
Totale 25.229
Nazione #
US - Stati Uniti d'America 14.743
RU - Federazione Russa 2.435
UA - Ucraina 1.526
CN - Cina 1.017
VN - Vietnam 776
GB - Regno Unito 724
SE - Svezia 667
IT - Italia 651
DE - Germania 621
SG - Singapore 599
FR - Francia 487
BR - Brasile 323
FI - Finlandia 142
NL - Olanda 67
HK - Hong Kong 51
PL - Polonia 41
EU - Europa 39
IE - Irlanda 27
JP - Giappone 26
BE - Belgio 19
CA - Canada 15
IN - India 15
AT - Austria 14
AR - Argentina 10
AU - Australia 10
TR - Turchia 9
ZA - Sudafrica 9
ES - Italia 7
IQ - Iraq 7
MA - Marocco 7
MX - Messico 7
GR - Grecia 6
BG - Bulgaria 5
CZ - Repubblica Ceca 5
LU - Lussemburgo 5
PT - Portogallo 5
AZ - Azerbaigian 4
CH - Svizzera 4
DK - Danimarca 4
EC - Ecuador 4
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
SK - Slovacchia (Repubblica Slovacca) 4
VE - Venezuela 4
BO - Bolivia 3
DZ - Algeria 3
IR - Iran 3
KR - Corea 3
KZ - Kazakistan 3
RS - Serbia 3
TN - Tunisia 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BD - Bangladesh 2
CL - Cile 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
PE - Perù 2
RO - Romania 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BT - Bhutan 1
CO - Colombia 1
CY - Cipro 1
EE - Estonia 1
EG - Egitto 1
GH - Ghana 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
KE - Kenya 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
MC - Monaco 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
PA - Panama 1
PH - Filippine 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 25.229
Città #
Fairfield 2.107
Woodbridge 1.882
Houston 1.678
Ann Arbor 1.318
Wilmington 1.051
Ashburn 913
Chandler 897
Seattle 840
Dong Ket 774
Cambridge 688
Dearborn 535
Nyköping 441
Jacksonville 426
Shenzhen 395
Southend 392
Moscow 379
Boardman 283
Singapore 215
Beijing 198
Lawrence 152
Princeton 151
Ogden 108
Shanghai 106
The Dalles 93
New York 91
San Diego 74
Grafing 69
Naples 68
Norwalk 63
Düsseldorf 62
London 52
Hong Kong 50
Des Moines 49
Groningen 49
Yubileyny 44
Los Angeles 41
Rome 41
Falls Church 39
Nanjing 36
Kraków 34
Jinan 31
Munich 31
Dublin 26
Bergamo 22
Shenyang 22
São Paulo 22
Milan 20
Hefei 19
Napoli 19
Brussels 18
Nanchang 18
Santa Clara 18
Edinburgh 17
Toledo 16
Auburn Hills 15
Dallas 15
Redwood City 15
Bremen 14
Kunming 14
Helsinki 13
Washington 13
Frankfurt am Main 12
Kilburn 12
Tokyo 12
Florence 11
Rio de Janeiro 11
Vienna 11
Belo Horizonte 10
Guangzhou 10
Lauterbourg 10
New Bedfont 10
Zhengzhou 10
Amsterdam 9
Tappahannock 9
Bari 8
Changsha 8
Hangzhou 8
Hebei 8
Matawan 8
Ningbo 8
Nürnberg 8
Wandsworth 8
Chicago 7
Chiswick 7
Curitiba 7
Haikou 7
Hounslow 7
Lanzhou 7
Tianjin 7
Boston 6
Brasília 6
Catania 6
Council Bluffs 6
Fukushima 6
Melbourne 6
Succivo 6
Taizhou 6
Acton 5
Clifton 5
Greenville 5
Totale 17.595
Nome #
Progressive parkinsonism, balance difficulties, and supranuclear gaze palsy 600
Compulsive drumming induced by dopamine agonists in Parkinson's disease: Another aspect of punding. 281
Effect of Global Postural Rehabilitation program on spatiotemporal gait parameters of parkinsonian patients: a three-dimensional motion analysis study. 271
Effects of Global Postural Reeducation on gait kinematics in parkinsonian patients: a pilot randomized three-dimensional motion analysis study 269
Reliability and validity of Italian version of the Dimensional Apathy Scale in Parkinson’s Disease 255
Common mutations in the LRRK2 exon 41 are not responsible for essential tremor in Italian patients 244
Hearing Impairment in Parkinson’s Disease: Expanding the Non-Motor Phenotype 241
Cognitive and affective theory of mind in patients with essential tremor 241
Validation of an Italian version of the 40-item University of Pennsylvania Smell Identification Test that is physician administered: our experience on one hundred and thirty-eight healthy subjects 234
Caffeine consumption and the 4-year progression of de novo Parkinson's disease 230
Apathy and related Executive Syndromes in Dementia associated with Parkinson’s Disease and in Alzheimer’s Disease 229
Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale 225
DRD3 Ser9Gly variant is not associated with essential tremor in a series of Italian patients 222
Pisa syndrome in Parkinson's disease and parkinsonism: clinical features, pathophysiology, and treatment 216
Abnormal eating behaviors in progressive supranuclear palsy 215
Differential neuropsychological profiles in Parkinsonian patients with or without vascular lesions 212
Apathy in Parkinson’s Disease: diagnosis, neuropsychological correlates, pathophysiology and treatment 211
Relationship between depression and cognitive dysfunctions in Parkinson’s disease without dementia 208
Side of onset does not influence cognition in newly diagnosed untreated Parkinson's disease patients 208
Impact of cognitive tasks on kinematic gait parameters in FTD patients 207
Effects of physical rehabilitation on gait pattern in parkinsonian patients with lateral trunk flexion: a three dimensional motion analysis investigation 207
Non-motor symptoms in early Parkinson’s disease: a 2-year follow-up study on previously untreated patients 206
Gender differences in non-motor symptoms in early, drug naïve Parkinson's disease 206
Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion 204
Resting-state functional connectivity associated with mild cognitive impairment in Parkinson's disease 202
Nonmotor predictors for levodopa requirement in de novo patients with Parkinson's disease 200
Parkinson’s patients with or without MCI classified according to wavelet analysis of lower limb joint angles in gait cycle 199
Anxiety is associated with striatal dopamine transporter availability in newly diagnosed untreated Parkinson's disease patients 199
The heterogeneity of early Parkinson's disease: a cluster analysis on newly diagnosed untreated patients 199
How does smoking affect olfaction in Parkinson's disease? 198
Insulin-like growth factor-1 and progression of motor symptoms in early, drug-naïve Parkinson's disease 196
The role of embodied simulation in mental transformation of whole-body images: evidence from Parkinson's disease 196
Gender and non motor fluctuations in Parkinson's disease: a prospective study 196
Affective theory of mind in patients with Parkinson's disease: comment 195
Pathological gambling in Parkinson's disease. A comprehensive review 192
A neuropsychological longitudinal study in Parkinson's patients with and without hallucinations 191
Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients. 190
Hypomorphic NOTCH3 mutation in an Italian family with CADASIL features 188
Diagnosis and treatment of restless legs syndrome in progressive supranuclear palsy 188
Is serum uric acid related to non-motor symptoms in de-novo Parkinson's disease patients? 188
Subthreshold depression and subjective cognitive complaints in Parkinson's disease 187
Segmental progression of cardinal motor symptoms in Parkinson's disease: a pilot study suggesting a practical approach to rate disease course in the early stages 187
Clinical clusters and dopaminergic dysfunction in de-novo Parkinson disease. 187
Teaching NeuroImages: pseudo-abnormal DaTscan findings in meningioma-induced parkinsonism 186
Assessment of apathy minimising the effect of motor dysfunctions in Parkinson’s disease: a validation study of the dimensional apathy scale 186
Apoptotic mechanisms in mutant LRRK2-mediated cell death 186
Cervico-oculo-Acoustic syndrome in a male with consanguineous parents 185
Resting-state brain connectivity in patients with Parkinson’s disease and freezing of gait 185
Cognitive performances and DAT imaging in early Parkinson's disease with mild cognitive impairment: a preliminary study 185
Electrophysiological comparison between males and females in HNPP 184
Season of birth and Parkinson's disease: possible relationship? 184
Do subjective memory complaints herald the onset of mild cognitive impairment in Parkinson disease? 184
Gender differences in non-motor symptoms in early Parkinson's disease: a 2-years follow-up study on previously untreated patients 183
Anxiety in early Parkinson's disease: Validation of the Italian observer-rated version of the Parkinson Anxiety Scale (OR-PAS) 183
Gait Patterns in Parkinsonian Patients With or Without Mild Cognitive Impairment 182
Insulin-like growth factor-1 predicts cognitive functions at 2-year follow-up in early, drug-naïve Parkinson's disease 182
Four-Year Longitudinal Study on Restless Legs Syndrome in Parkinson Disease. 181
The use of University of Pennsylvania Smell Identification Test in the diagnosis of Parkinson's disease in Italy 180
Apathy and striatal dopamine transporter levels in de-novo, untreated Parkinson's disease patients 178
Cognitive dysfunctions in occipital lobe epilepsy compared to temporal lobe epilepsy. 177
Neuropsychological profile of adult patients with non symptomatic occipital lobe epilepsies 176
Cortical thickness changes in patients with Parkinson's disease and impulse control disorders. 176
Functional involvement of central cholinergic circuits and visual hallucinations in Parkinson's disease 176
The "eye of the tiger" sign in pure akinesia with gait freezing 175
Early MRI findings in Acquired hepatocerebral degeneration 175
Gender and non motor fluctuations in Parkinson's disease: A prospective study 175
Normative data for the Montreal Cognitive Assessment in an Italian population sample 172
Simultaneous absence of dopamine D1 and D2 receptor-mediated signaling is lethal in mice 170
Uric acid relates to dopamine transporter availability in Parkinson's disease 170
Anxiety and cognition are associated with dopaminergic dysfunction in de novo Parkinson’s disease 170
Bilirubin and Uric Acid: Two Different Anti-oxidants in Parkinson's Disease 170
The closing-in phenomenon in Parkinson's disease 170
A metabolomic signature of treated and drug-naïve patients with Parkinson’s disease: a pilot study 170
Cerebellar and pyramidal dysfunctions, palpebral ptosis and weakness as presenting symptoms of PARK-2 169
Impulse control disorders and cognitive dysfunctions in patients with Parkinson's disease 169
Unawareness of dyskinesias in Parkinson's and Huntington's diseases 167
Linkage exclusion in Italian families with hereditary essential tremor 166
Comment on Poletti et al. “Affective theory of mind in patients with Parkinson's disease”. 165
Impulse Control Disorders induced by Rasagiline as adjunctive therapy for Parkinson's disease: Report of 2 Cases 165
Hemi-Restless Legs Syndrome induced by Clebopride 165
Dopamine transporter availability in motor subtypes of de novo drug-naïve Parkinson's disease 163
Neuropsychological correlates of Pisa syndrome in patients with Parkinson's disease 163
The relationship between cerebral vascular disease and parkinsonism: the VADO study 162
Link between non-motor symptoms and cognitive dysfunctions in de-novo, drug naïve PD patients 160
Cognitive Dysfunctions and Pathological Gambling in Patients with Parkinson’s Disease 160
Hearing impairment in Parkinson’s disease: expanding non motor phenotype 157
No evidence of association between CAG expansions and essential tremor in a large cohort of Italian patients 156
Comparative neuropsychological profile of pathological gambling, hypersexuality, and compulsive eating in Parkinson's disease 156
The non-motor side of the honeymoon period of Parkinson's disease and its relationship with quality of life: a 4-year longitudinal study 155
Lower serum uric acid is associated with mild cognitive impairment in early Parkinson's disease: a 4-year follow-up study. 153
Cortical thickness in Parkinsonians with impulse control disorders: A comment 152
Impact of anxiety, apathy and reduced functional autonomy on perceived quality of life in Parkinson's disease 152
Ping-pong gaze: Sherrington would not have done it better 151
Mild Cognitive Impairment in drug-naïve PD patients is associated with cerebral hypometabolism 151
Quitting smoking: an early non-motor feature of Parkinson's disease? 150
The role of Vitamin D levels on neuropsychological profile of patients with Parkinson’s Disease 149
Extended release levodopa at bedtime as a treatment for nocturiain Parkinson's disease: An open label study 149
Pallidal stimulation in atypical pantothenate kinase-associated neurodegeneration: six-year follow-up 148
Association between dopaminergic dysfunction and anxiety in de novo Parkinson's disease 147
Auditory function and speech discrimination abilities are impaired in progressive supranuclear palsy 145
Totale 19.121
Categoria #
all - tutte 97.264
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 97.264


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202047 0 0 0 0 0 0 0 0 0 0 0 47
2020/20213.202 267 88 336 187 426 105 337 39 148 241 136 892
2021/20221.528 189 151 44 402 84 102 163 120 98 95 50 30
2022/20232.611 310 164 143 315 236 436 106 312 312 75 150 52
2023/20241.229 91 44 449 46 26 106 32 81 171 61 18 104
2024/20254.394 61 360 26 109 96 401 1.121 1.358 336 238 206 82
Totale 25.520